Evidence map›Paper›PMID 39815692›Full record

ArticleJournal of biomedical materials research. Part A2025

Promoting Angiogenesis/Osteogenesis by a New Copper/Magnesium Hydroxide Hybrid Nanoparticle: In Vitro and In Vivo Investigation.

Parsa Khalkhali, Meisam Omidi, Daniela S Masson-Meyers, Babak Akbari, Mohammad Mehdi Dehghan, Hossein Aminianfar, Saeed Farzad-Mohajeri, Vahid Mansouri, Amin Nikpasand, Lobat Tayebi

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Parsa KhalkhaliDepartment of Life Science Engineering, Faculty of new Sciences and Technologies, University of Tehran, Tehran, Iran.
Meisam OmidiMarquette University School of Dentistry, Milwaukee, Wisconsin, USA.
Daniela S Masson-MeyersMarquette University School of Dentistry, Milwaukee, Wisconsin, USA.
Babak AkbariDepartment of Life Science Engineering, Faculty of new Sciences and Technologies, University of Tehran, Tehran, Iran.ORCID 0000-0002-7175-3742
Mohammad Mehdi DehghanDepartment of Surgery & Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.ORCID 0000-0002-8825-9070
Hossein AminianfarInstitute of Biomedical Research, University of Tehran, Tehran, Iran.
Saeed Farzad-MohajeriDepartment of Surgery & Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.ORCID 0000-0003-4694-347X
Vahid MansouriProteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amin NikpasandDepartment of Veterinary Clinical Sciences, Karaj Branch, Islamic Azad University, Karaj, Iran.
Lobat TayebiMarquette University School of Dentistry, Milwaukee, Wisconsin, USA.ORCID 0000-0003-1947-5658

Funding

Synthetic osteo-odonto-keratoprosthesis (OOKP, Tooth-in-Eye surgery)R21EY035480 · NEI · MARQUETTE UNIVERSITY · PI TAYEBI, LOBAT · 2023 to 2024
$634k
Vascularization of critical-sized craniomaxillofacial defectsR56DE029191 · NIDCR · MARQUETTE UNIVERSITY · PI TAYEBI, LOBAT · 2021 to 2021
$363k
NEI NIH HHS R21 EY035480NIDCR NIH HHS R56 DE029191NIH HHS 1R21EY035480-01NIH HHS 1R56DE029191-01A1
6 · The paper itself

Abstract

In this study, a new hybrid nanoparticle composed of magnesium hydroxide and copper oxide (Mg(OH)

Indexed as

CopperHuman Umbilical Vein Endothelial CellsMagnesium HydroxideNeovascularization, PhysiologicOsteogenesisTissue ScaffoldsAngiogenesisAnimalsGelatinHumansMaleMiceNanoparticlesPolyestersRatsRats, Sprague-DawleyCopperGelatinMagnesium HydroxidepolycaprolactonePolyestersangiogenesis nanoparticlebone angiogenesisbone tissue engineeringcopper/magnesiumcopper/magnesium hydroxide hybrid nanoparticle

Identifiers

PMID39815692
PMCPMC12068790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.